Related Experiment Videos
5-Hydroxytryptamine and 5-hydroxytryptamine-3 receptor antagonists
1Dept. of Gastroenterology, St Bartholomew's Hospital, London, U.K.
Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1991
Summary
5-Hydroxytryptamine (5-HT) plays a key role in gut function and disease. 5-HT receptor antagonists are valuable for managing carcinoid syndrome, emesis, and potentially functional bowel disorders.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- 5-Hydroxytryptamine (5-HT) is abundant in the gastrointestinal tract, influencing motility and secretion.
- Its precise physiological roles are still being investigated, but it's implicated in peristalsis and the migrating motor complex.
- 5-HT's contribution is clearer in disease states like chemotherapy-induced emesis, carcinoid syndrome, and cholera toxin effects.
Purpose of the Study:
- To explore the functions of 5-HT in the gastrointestinal tract.
- To understand the therapeutic potential of 5-HT receptor antagonists.
- To investigate the role of 5-HT in regulating gut motility, secretion, and visceral sensation.
Main Methods:
- Utilizing 5-HT receptor antagonists to elucidate 5-HT functions.
- Analyzing the effects of these antagonists in various gastrointestinal conditions.
- Investigating the modulation of visceral sensation by 5-HT3 receptor antagonists.
Main Results:
- 5-HT receptor antagonists are effective in managing carcinoid syndrome and chemotherapy-induced emesis.
- These antagonists show promise in modulating gut motility and inhibiting secretory states.
- 5-HT3 receptor antagonists may alleviate symptoms in functional bowel disorders, including pain and altered bowel frequency.
Conclusions:
- 5-HT receptor antagonists are crucial therapeutic agents in gastroenterology.
- Further research into 5-HT's role could lead to novel treatments for motility and secretory disorders.
- 5-HT3 receptor antagonists offer potential for managing visceral hypersensitivity and functional bowel symptoms.